Researchers at the Sanford Stem Cell Institute have taken the fight against rare diseases to the lab, to patients’ bedsides and even to outer space.

UC Riverside researchers have developed an oxygen-delivering gel capable of healing injuries that might otherwise progress to limb loss.

Written words can do much more than communicate.

UC labs are developing new treatments that don’t just prevent damage from getting worse, but — for the first time in medical history — actually help the heart heal.

A new study discovers that early pregnancy in mice reduces buildup of ‘confused’ cells that could lead to breast cancer later in life.

Restoring a single heart protein shows promise for improving multiple forms of arrhythmogenic cardiomyopathy.

By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative breast cancer, the most aggressive and difficult-to-treat subtype of the disease.

Even as they’re pushing the boundaries of research and discovery with AI, UC scientists are asking the right questions about the transformation this technology brings.

Researchers are developing functional, patient-specific livers using 3D bioprinting and stem cell technology to eliminate the need for donor organs.

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC Berkeley.

Researchers at UC San Francisco have devised a method to identify pneumonia — using both genetic information and AI — that could curb the overuse of antibiotics.

UC Riverside-led mouse study finds microplastics affect male and female offspring differently.